# Treatment of Severe Infection With Antihyperlipidemia Drug

> **NCT03634293** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Wolfson Medical Center** · enrollment: 712 (estimated)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DRUG:** Alirocumab Injectable Product
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03634293
- **Lead sponsor:** Wolfson Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-02
- **Target enrollment:** 712 (ESTIMATED)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634293, "Treatment of Severe Infection With Antihyperlipidemia Drug". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03634293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*